Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on June 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Systematic Targeting Of MicroPlastics (STOMP)

Closed
ARPA-H-SOL-26-152Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

about 24 hours ago

DEADLINE

in 5 days
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

Show more

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative solutions through an Other Transaction Agreement for the Systematic Targeting Of MicroPlastics (STOMP) program, with a proposal deadline of June 22, 2026. This solicitation, identified as ARPA-H-SOL-26-152, targets the development of technologies to measure, understand, and remove micro- and nano-plastics (MNPs) from human and animal systems, with a focus on fibers and irregular fragments that pose heightened biological risks. The program is structured into three technical areas: Technical Area 1 (TA1) requires a validated, standardized methodology for MNP detection in biological samples by Month 9 and a low-cost, rapid clinical quantification system under $50 and 15 minutes per test; Technical Area 2 (TA2) investigates the trafficking and accumulation mechanisms of MNPs in key organ systems, with updated metrics for TA2.1 and microplastics samples as of Amendment 3; Technical Area 3 (TA3), focused on removal methods, will not be solicited until near Month 24. Proposals must be submitted in four volumes — Technical and Management, Cost, Draft OT Response, and Administrative and National Policy Requirements — adhering strictly to formatting rules, including a 25-page limit for Volume I, exclusion of cover and supporting materials from that limit, and mandatory use of English with searchable PDFs. Proposal submissions require prior submission of a Solution Summary and are limited to entities outside federally funded research centers; non-U.S. entities may participate only under strict compliance with security, export control, and non-disclosure requirements, while ARPA-H prioritizes U.S.-based work. Financial proposals must include a detailed cost breakdown by direct labor, subcontracts, materials, equipment, travel, indirect costs, and cost sharing, broken down further by TA1 and TA2 subcomponents, with a simplified materials estimate acceptable initially and full itemization required post-selection. All awards involve negotiated Articles rather than standard FAR clauses, governed by an Agreements Officer with sole authority to modify or terminate, and payments are milestone-based according to a defined Payment Schedule. Key compliance obligations include annual certifications that principal investigators and senior personnel are not involved in malign foreign talent recruitment programs, disclosure of all conflicts of interest and foreign affiliations, adherence to Section 889 telecommunications prohibitions, and the ability to safeguard Controlled Unclassified Information. The agreement survives in full for core provisions including

General Info

ARPA-H seeks milestone-based OT agreements for innovative microplastic detection and mitigation technologies.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Washington, DC, USA

Set-Aside

NONE

Documents

(7)

ARPA-H STOMP ISO Solicitation ARPA-H-SOL-26-152 Amendment 2

PDFamendment

STOMP_ISO_Volume+II_ARPA-H+COST+PROPOSAL+SPREADSHEET+%28Other+Transaction%29.xlsx

XLSX

STOMP_ISO_ARPA-H-SOL-26-152_Amendment+1.pdf

PDF

STOMP_ISO_Volume+I_ARPA-H+Preliminary+Task+Description+Document+%28TDD%29.docx

DOCX

ARPA-H STOMP Innovative Solutions Opening ISO ARPA-H-SOL-26-152

PDFiso

STOMP+ISO_ARPA-H-SOL-26-152+Amendment+3.pdf

PDF

STOMP_ISO_Volume+III_ARPA-H+Sample+OT+Agreement.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

3 updates
PhaseClosed
Posted

Solicitation

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Amendment 3

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Contacts1 person available
OfficeWashington, DC, 20005, USA
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
View Agency Profile
Office AddressWashington, DC, 20005, USA
Contacts
The STOMP Team

Full Description

Show more

June 2, 2026 - Amendment 3 to STOMP ISO ARPA-H-SOL-26-152. This amendment incorporates the following changes:


1. Figure 8: TA2.1 metrics and Section 2.5 Microplastics Samples has been updated. 


All other terms and conditions remain unchanged. 


________________________________________________________________________


May 6, 2026 - Amendment 2 to STOMP ISO ARPA-H-SOL-26-152. This amendment incorporates the following changes:


1. Corrects a typo under Figure 4: TA1.2 metrics, from 50 µm to 50 nm. 


2. Section B. Cost and Pricing Data Support under page 46 has been revised. The requirements that have been removed are only necessary if proposers are selected for negotiations.  


All other terms and conditions remain unchanged. 


____________________________________________________________


April 20, 2026 - Amendment 1 to STOMP ISO ARPA-H-SOL-26-152. This amendment corrects the Figure number on Page 11 and incorporates Figure 6 on Page 15.


_____________________________________________________________________


All questions submitted to the ISO will be compiled and addressed. Responses will be posted to the STOMP Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQ page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/stomp/faqs


_____________________________________________________________________


The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the Systematic Targeting Of MicroPlastics (STOMP) Program. ARPA-H anticipates multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the STOMP_ISO_ARPA-H-SOL-26-152 and assciated attachments.


Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-150, for information regarding the STOMP Proposers’ Day. Special Notice (SN), ARPA-H-SN-26-150, is an independent announcement and is not attached to this ISO announcement.

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
New
Federal
Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program
Solicitation # 7599226SN106
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns (SBCs) for its Fiscal Year 2026 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The program aims to stimulate technological innovation and increase private sector commercialization of federal research and development. Eligible participants must be for-profit businesses located in the United States with no more than 500 employees. The solicitation focuses on seven high-impact research topics: the development of an annual fertility test, versatile bioadhesives, a universal platform for living adaptive toxin-removal, non-surgical therapies for endometriosis, rapid diagnostics for multi-system autoimmune disease, a virtual human brain for neurosurgical robotics, and the ARPA-H Lineage topic for advancing previously funded technologies. The submission process is structured in two stages. Stage 1 requires a Solution Summary, SBA proof of registration, and various certifications. Stage 2 involves a more detailed submission including a technical presentation, a Task Description Document, a cost proposal, and a key personnel worksheet. Awards are based on technical merit, novelty, team experience, and the path to health outcomes, subject to funding availability and security risk assessments. The program utilizes fixed payment milestones and provides additional Technical and Business Assistance (TABA) funding of up to 6,500 dollars for Phase I and 50,000 dollars for Phase II projects. All proposers must maintain an active SAM.gov registration and adhere to strict marking requirements for proprietary technical data.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 24 hours ago

DEADLINE

in 19 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS